GNIPST BULLETIN 2016

23-09-2016

23rd September, 2016

Volume No.: 59 Issue No.: 02

Vision
To develop responsible citizens who would be professionally equipped to think globally and act
locally and become reformers of society to meet the challenges of future.
Mission
To impart high quality pharmaceutical science, technology and management education to the budding
professionals and provide the ambience needed for developing requisite skills to make a mark of
excellence in Education, Research, Business , Industry and achieve highest personal standards.
Contents
Message from PRINCIPAL
Editorial board
Historical article
News Update
Knowledge based Article
Disease Related Breaking News
Upcoming Events
Drugs Update
Campus News
Students Section
Editors Note

Archive

GNIPST Photo Gallery

For your comments/contribution

OR For Back-Issues,
mailto:gnipstbulletin@gmail.com

GURU NANAK INSTITUTE OF PHARMACEUTICAL

SCIENCE AND TECHNOLOGY
Website: http://gnipst.ac.in

23-09-2016

MESSAGE FROM PRINCIPAL

"It can happen. It does happen.

But it can't happen if you quit." Lauren Dane.

We are what we repeatedly do.

Excellence then is not an act, but a habit. Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the
last years editors and congratulate the newly selected editors for the current year.
Our first consideration is always in the best interest of the students. Our goal is to promote academic
excellence and continuous improvement.
I believe that excellence in education is aided by creating a learning environment in which all learners are
supported in maximizing their potential and talents. Education needs to focus on personalized learning
and instruction, while promoting an education system that is impartial, universally accessible, and meeting
the needs of all students.
It is of paramount importance that our learners have sufficient motivation and encouragement in order to
achieve their aims. We are all very proud of you, our students, and your accomplishments and look
forward to watching as you put your mark on the profession in the years ahead.
The call of the time is to progress, not merely to move ahead. Our progressive Management is looking
forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in
this direction and fruits of these efforts will be received by our students in the near future. Our Teachers
are committed and dedicated for the development of the institution by imparting their knowledge and play
the role of facilitator as well as role model to our students.
The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive
challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic
needs of our students.
I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the
opportunities and meet the challenges with purpose and determination.
Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on
this path.
My best wishes to all.
Dr. A. Sengupta

Click here to go at the top

1

23-09-2016

EDITORIAL BOARD
CHIEF EDITOR
EDITOR
ASSOCIATE EDITOR

DR. ABHIJIT SENGUPTA

MS. JEENATARA BEGUM
MR.
DIPANJAN
MANDAL

HISTORICAL ARTICLE

Franz Boas
1858-1942

Widely considered to be one of the greatest and most influential

anthropologists ever, Franz Boas was a German-American
scientist, who is also known as the Father of Modern
Anthropology. He was the first person to implement the scientific
method into the study of human cultures and societies.
Early Life and Education:
Born in Minden, Westphalia, Franz Boas showed an early interest
in both nature and natural sciences. He studied at the universities
of Heidelberg, Bonn, and Kiel, and finally got his Ph.D. in physics
with a minor in geography from the University of Kiel in 1881.
Boas worked in Baffinland, Canada, from 1883 to 1884, while from
1885 to 1886; he conducted field research in several museums on
the North Pacific Coast of North America. He was also an
important part of a project involving the cultures of Native
Americans which lasted almost one year.
Contributions and Achievements:
Franz Boas was the most important figure in 20th century North
American anthropology. He laid down the four-field structure of
the discipline around cultural, physical, linguistic and
archaeological disciplines pertaining to the American Indian. He
also trained many professional anthropologists. Boas made
memorable contributions to the changes in immigrant head form
undercut eugenics arguments and lessened the significance of
anthropometric measures of race.
Click here to go at the top
2

23-09-2016

The archaeological works of Franz Boas were almost cursory.

While studying culture, his theoretical contributions dealt with
the critique of evolution. He destroyed the rationalist theories of
human nature. His historical particularism, his insistency on
stringent ethnographic method, and his stress on the native point
of view were pivotal to the development of modern anthroplogy.
Later Life and Death:
Franz Boas oversaw the Columbia Anthropology Department for
more than four decades. Boas died on 21 December, 1942. He was
84 years old.

NEWS UPDATE

Ancient remedy becomes novel approach to

treating clostridium difficile infection: (16th
September, 2016)

The epidemiology of Clostridium difficile (C. diff) infection,

clinical presentation of infection, diagnosis and various therapies
including fecal microbiota transplant have been the focus of recent
research, all laid out in a new report.

Scientists spot genes that make some sarcomas

less aggressive: (21st September, 2016)
A set of genes they say make sarcoma cells less aggressive has been
discovered by researchers. They hope to turn the discovery into
new therapeutic approaches to fight metastatic cancers.

Blood biomarkers in drug-resistant cancer tumor

cells identified: (21st September, 2016)

While searching for a non-invasive way to detect prostate cancer

cells circulating in blood, researchers have identified some blood
markers associated with tumor resistance to two common
hormone therapies.

Click here to go at the top

3

23-09-2016

Immune and targeted therapies with radiation

therapy improves outcomes for melanoma brain
metastases patients, say researchers: (21st
September, 2016)

Researchers have sought to determine if patients with melanoma

brain metastases treated with immune and targeted therapies had
improved outcomes over patients treated with conventional
chemotherapy. They retrospectively analyzed data from 96
patients with melanoma brain metastases who were treated with
stereotactic radiation therapy within 3 months of different
targeted therapies (antiPD-1 therapy, antiCTLA-4 therapy,
BRAF inhibitor plus a MEK inhibitor, or a BRAF inhibitor alone)
or conventional chemotherapy.

New genetic tool created to identify people at

risk of coronary heart disease: (21st September,
2016)

A new genetic risk score that could help to identify individuals at

risk of coronary heart disease (CHD) much earlier and potentially
improve its prevention has been developed by scientists.

Care home dementia study finds failure to

reduce
antipsychotic
prescribing:
(20th
September, 2016)
There has been no sustained reduction in the prescription of
antipsychotics to UK dementia patients, despite government
guidance, according to a report.

Researchers find a potential signature of

cognitive function in people living with HIV: (20th
September, 2016)
A unique epigenetic footprint has been found in specific types of
immune cells from blood that can identify individuals with HIV

Click here to go at the top

4

23-09-2016

that have a range of impairments in cognitive function. Reliable

biomarkers such as that identified by the researchers offer insight
into how HIV-associated cognitive impairment develops but also
promises improved diagnostic testing and improved treatment
decisions.

How to power up graphene implants without

frying cells: (23rd September, 2016)

In the future, our health may be monitored and maintained by tiny

sensors and drug dispensers, deployed within the body and made
from graphene -- one of the strongest, lightest materials in the
world. Graphene is composed of a single sheet of carbon atoms,
linked together like razor-thin chicken wire, and its properties
may be tuned in countless ways, making it a versatile material for
tiny, next-generation implants.
For detail mail to editor

KNOWLEDGE BASED ARTICLE

Expanded indications for Ilaris for three rare

diseases

There are three new indications for Ilaris (canakinumab). The new
indications are for rare and serious auto-inflammatory diseases in
adult and pediatric patients:
Tumor Necrosis Factor Receptor Associated Periodic
Syndrome (TRAPS);
Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate
Kinase Deficiency (MKD); and
Familial Mediterranean Fever (FMF).
All three syndromes are hereditary diseases that are characterized
by periodic attacks of fever and inflammation, as well as severe
muscle pain. There are no previously approved therapies for
TRAPS or HIDS/MKD.
For the first time, patients with TRAPS and HIDS/MKD, two
painful and life altering diseases, have access to a treatment that
Click here to go at the top
5

23-09-2016

may help improve their quality of life, said Badrul Chowdhury,

M.D., Ph.D, director of the Division of Pulmonary, Allergy and
Rheumatology Products in FDAs Center for Drug Evaluation and
Research.
Ilaris was previously approved for another periodic fever syndrome
called Cryopyrin-Associated Periodic Syndromes (CAPS) and for
active systemic juvenile idiopathic arthritis. Health care
professionals should review the prescribing information in the
labeling for detailed information about the approved uses.
Approvals for the new indications were based on clinical studies,
including safety, efficacy and pharmacokinetic data. The most
common adverse reactions for these indications are injection site
reactions and being more susceptible to catching colds.
Ilaris can cause serious side effects, including increased risk of
serious infections. Ilaris can lower the immune systems ability to
fight infections. Other serious side effects include decreased ability
to fight infections (immunosuppression) and allergic reactions.
Patients experiencing any symptoms of an allergic reaction should
call their healthcare provider, including: rash, itching and hives,
difficulty breathing or swallowing, and dizziness or feeling faint.
Patients should not get live vaccines if receiving Ilaris. Patients
should not receive Ilaris if they are allergic to canakinumab or any
of the ingredients in Ilaris.
Ilaris is manufactured and distributed by Novartis
Pharmaceuticals Corporation, of East Hanover, New Jersey.
The FDA, an agency within the U.S. Department of Health and
Human Services, protects the public health by assuring the safety,
effectiveness, security of human and veterinary drugs, vaccines and
other biological products for human use, and medical devices. The
agency is also responsible for the safety and security of our nations
food supply, cosmetics, dietary supplements, products that give off
electronic radiation, and for regulating tobacco products.
Jeenatara Begum
Assistant Professor
GNIPST
Click here to go at the top
6

23-09-2016

DISEASE RELATED BREAKING NEWS

Middle East respiratory syndrome coronavirus

(MERS-CoV) Austria: (20th September, 2016)

On 8 September 2016 the National IHR Focal Point for Austria

notified WHO of a laboratory confirmed case of Middle-East
respiratory syndrome coronavirus (MERS-CoV) infection. This is
the second case of MERS-CoV in Austria. (The first MERS-CoV
case in Austria was notified on 30 September 2014).
Read more

UPCOMING EVENTS

IPGA sponsored National Seminar on Current status of

Regulatory Affairs for Pharmaceuticals wll be held on 24th to 25th
September, 2016 at B.N.College of Pharmacy, Bhopal Nobles
University, Udaipur.

DRUGS UPDATES

FDA Approves Amjevita (adalimumab-atto), a

Biosimilar to Humira: (23rd September, 2016)

The U.S. Food and Drug Administration today approved Amjevita

(adalimumab-atto) as a biosimilar to Humira (adalimumab) for
multiple inflammatory diseases.
Read more

CAMPUS NEWS
NBA visit:
The experts of National Board of Accreditation or NBA will be
going to visit GNIPST on 24th September and 25th September,
2016.

Click here to go at the top

7

23-09-2016

Freshers welcome programme:

On 12th September GNIPST organized the Freshers welcome
programme Kulrav 2k16.
GNIPST Football Match 2016:
On 31st August and 1st September GNIPST sports club organized a
football match. The winner of the football match was B.Pharm 3rd
year.
Recent Trends in Pharmaceutical Research:
A Science Awareness Programme comprising of seminar on
Recent Trends in Pharmaceutical Research was organized by
GNIPST in collaboration with National Academy of Science India
(NASI) on 30th august, 2016 from 2 pm to 4.30 pm at GNIPST
auditorium. Plantation programme was also organized by Eco club.
Dr. Hemanta Kumar Majumder, gave his valuable lecture on
Modern Biology & its Evolution and Dr. Pijush K Das delivered
his lecture on Site specific Drug Targeting Magic Bullet
approach.
World Photography Day celebration:
On 19th August 2016 GNIPST celebrated World Photography Day
at Dakhineswar.
Friendly Football Match:
On 15th August 2016 GNIPST organised a friendly football match
with Alumni members.
Farewell 2016:
On 25th May 2016 GNIPST celebrated the farewell programme for
the final year students. Best of luck to all final year students for
their future life.
ALUMNI MEMBERS 2016:
Congratulations to new Alumni Members of GNIPST.

Click here to go at the top

8

23-09-2016

Placement Record 2016:

SL
NO

COMPANY NAME

DR. LAL PATH LAB

APOLLO
PHARMACY

36

25

ABBOTT INDIA

74

03

HETERO DRUGS

18

Production,
QC and QA

ERIS LIFE SCIENCES

01

18 (Waiting
for final
interview)
01 (Joined)

JUPITER
PHARMACEUTICALS

05

01 (Joined)

Production,
QC and QA

GOVT PHARMACIST

4 (Joined)

Hospital
Pharmacist

ALCHEMIST EYE
HOSPITAL

Hospital
Pharmacist

21

10

OPTIVAL HEALTH
SOLUTIONS PVT.
LTD. (MEDPLUS)
NESTLE INDIA LTD

2 (Waiting for
final
interview)
21

08

02

11

LUPIN

01

01

12

GSK
PHARMACEUTICAL
LTD
OAK
PHARMACEUTICAL

05

02 (1 of them
already joined)

Sales and
Marketing

06

02 (Joined)

Sales and
Marketing

13

NUMBER OF
NUMBER OF
STUDENT
STUDENT
APPEARED/APPLIED SELECTED
64
7

JOB
PROFILE
Sales,
Marketing and
office assistant
Hospital and
retail chain
pharmacist
Sales and
Marketing

Sales and
Marketing

Community
Pharmacist
Nutrition
Officer
Trainee
Sales and
Marketing

Click here to go at the top

9

23-09-2016

IPA Bengal Pharma & Healthcare trust scholarship 2016:

Congratulations to Rudradip Das, student of B.Pharm 3rd year has

been awarded IPA Bengal Pharma & Healthcare trust scholarship
2016.
Accreditation by NAAC:
SL.
NAME
OF
STATE
CGPA(out
GRADE
NO.
THE
of scale 4)
INSTITUTE
01
Guru
Nanak
West
2.70
B
Institute
of
Bengal
Pharmaceutical
Science
And
Technology,
Kolkata-700114

GPAT 2016 Result:

The following B.Pharm. final year students have qualified, GPAT2016. We congratulate them all.
Aishika Datta
Mainak Chatterjee
Indira Saha
Priyanka De
Aheli Mukherjee
Soumya Guha
Debanjana Das
Debalina Datta
Evana Patra
Himadrija Chatterjee
IRIS 2016:
GNIPST organized colllege fest IRIS 2016 from 11th to 13th March,
2016.
Result of different events:
Intracollege Quiz competition:
1st: Arani Roy and Dipayan Nath
Click here to go at the top
10

23-09-2016

2nd: Bhaskar Singha and Pratik Nandi

Intracollege Painting competition:
1st: Swagata Paul
2nd: Aviraj Pathak
3rd: Dippyoman Guha
Group Dance Competition:
Karma Group
Intercollege Solo Dance Competition:
1st : Monodipa Ghosh
2nd: Aditya Paul (NIT)
Antaksari Competition:
1st: Sunanda and Aparupa
2nd: Meghna and Joyita
3rd: Arpita and Pami
Intercollege Solo Singing Competition:
1st: Arpita Sarkar
2nd: Arvind Raj (Sudhir Chandra College)
3rd: Priyam Mondal (Supreme College)
Intercollege Band Competition:
1st: D Errors
2nd: Mukti
3rd: GNIPST band
Fashion:
Best Male: Md. Nadeem Shah
Best Female: Sweta
Best Couple: Md. Nadeem Shah and Susmita Kar
Blood donation Camp 2016:
On 4th March 2016 Social Service club and Alumni Association
of GNIPST organized a Blood donation camp in association with
Association of voluntary Blood Donars, West Bengal.
Click here to go at the top
11

23-09-2016

Reminiscence & 1st Alumni meet 2016:

On 28th February 2016 GNIPST organized the Reunion programme
Reminiscence & 1st Alumni meet 2016.
National Assessment and Accreditation Council (NAAC):
A NAAC peer team completed a three-day inspection (17th
February to 19th February, 2016) of GNIPST to evaluate its
academic credibility and infrastructure on Friday.
Saraswati Puja 2016:
On 13th February 2016 the students of GNIPST celebrated
Saraswati Puja at GNIPST campus.

STUDENTS SECTION
WHO CAN ANS WER FIRS T????

Identify the Person

Answer of Previous Issues Qestion:

Irene Curie

Send

your
thoughts/
Quiz/Puzzles/games/write-ups or any other
contributions for Students Section& answers
of this Section at gnipstbulletin@gmail.com
EDITORS NOTE
It is a great pleasure for me to publish the 2nd issue of 59th Volume
of GNIPST BULLETIN. All the followers of GNIPST BULLETIN
Click here to go at the top
12

23-09-2016

are able to avail the bulletin through facebook account GNIPST

bulletin I am very much thankful to all the GNIPST members and
readers who are giving their valuable comments, encouragements
and supports. I am also thankful to Dr. Abhijit Sengupta, Director
of GNIPST for his valuable advice and encouragement. Special
thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar
and Mr. Soumya Bhattacharya for their kind co-operation and
technical supports. Thank you Mr. Soumya Bhattacharya for the
questionnaires of the student section. An important part of the
improvement of the bulletin is the contribution of the readers. You
are invited to send in your write ups, notes, critiques or any kind of
contribution for the forthcoming special and regular issue.
ARCHIVE
OTHERS:
AICTE has sanctioned a release of grant under Research
Promotion Scheme (RPS) during the financial year 2012-13to
GNIPST as per the details below:
a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical
Science & Technology.
b. Principal Investigator: Dr. LopamudraDutta.
c. Grant-in-aid sanctioned:Rs. 16,25000/- only
d. Approved duration: 3 years
e. Title of the project: Screening and identification of potential
medicinal plant of Purulia & Bankura districts of West Bengal
with respect to diseases such as diabetes, rheumatism, Jaundice,
hypertension and developing biotechnological tools for enhancing
bioactive molecules in these plants.

Click here to go at the top

13

23-09-2016

Activity Clubs of GNIPST:

Name of Club
CULTURAL
DEBATE AND EXTEMPORE
ECO
LITERARY AND PAINTING
PHOTOGRAPHY

Member Faculty
Ms. Priyanka Ray
Mr. Soumya Bhattacharya
Ms. Sumana Roy
Ms. Jeenatara Begum
Ms. Sanchari Bhattacharya and
Mr. Abir Koley
SCIENCE AND INNOVATIVE Mr. Samrat Bose
MODELLING
SOCIAL SERVICES
Dr. Asis Bala
SPORTS
Mr. Debabrata GhoshDastidar

Click here to go at the top

14